CHUV
Lausanne Ch-1011
2 studies enrolling now · 15 studies all time
What they study most
Breast Cancer, C3 Glomerulonephritis, C3 Glomerulopathy, C3G, Cancer, Cerebrovascular Accident, Chronic Coronary Insufficiency, Complement 3 Glomerulonephritis, Complement 3 Glomerulopathy, Complement 3 Glomerulopathy (C3G), Critical Illness, Dense Deposit Disease (DDD)
Studies at this site
- A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer — Recruiting now
- Efficacy and Safety of the CG-100 Intraluminal Bypass Device — Recruiting now
- A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A) — Running, not enrolling
- A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants — Completed
- Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN — Completed
- A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer — Completed
- A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer — Completed
- A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) — Completed
- ASSIST Registry Studying Various Operator Techniques — Completed
- Pullback Pressure Gradient (PPG) Global Registry — Running, not enrolling
- Multicentric Prospective Validation of the Zurich Pituitary Score — Completed
- Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients — Completed
- The Intravascular Cooling in the Treatment of Stroke 2/3 Trial — Stopped early
- Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults — Completed
- Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) — Completed